BIO-key International
BKYI
4 hedge funds and large institutions have $253K invested in BIO-key International in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
198% more capital invested
Capital invested by funds: $85K → $253K (+$168K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
33% more funds holding
Funds holding: 3 → 4 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$152K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$11.8K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$7.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$12K |
| 2 |
TL
TrueWealth LLC
Atlanta,
Georgia
|
-$1K |
BKYI Hedge Fund Activity: Q2 2020 in Review
4 of the 4,887 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q2 2020, worth a combined $253K — up 198% from $85K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BKYI positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $152K. The largest seller was HRT Financial, exiting entirely with an estimated $12K sold.
- 4 institutional investors held BIO-key International (BKYI) as of Q2 2020, up from 3 in Q1 2020.
- Funds reported $253K of BIO-key International stock for Q2 2020, up 198% quarter-over-quarter.
- 3 funds opened new BIO-key International positions in Q2 2020 and 2 closed out, a net change of +1 holder.
- The largest BIO-key International buyer in Q2 2020 was Renaissance Technologies, an estimated $152K added.
- The largest BIO-key International seller in Q2 2020 was HRT Financial, an estimated $12K sold.
Based on aggregated 13F filings for Q2 2020.